Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Assets Average (2016 - 2025)

Historic Assets Average for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $17.3 million.

  • Lipocine's Assets Average fell 2076.41% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 2076.41%. This contributed to the annual value of $22.8 million for FY2024, which is 2482.89% down from last year.
  • Per Lipocine's latest filing, its Assets Average stood at $17.3 million for Q3 2025, which was down 2076.41% from $19.5 million recorded in Q2 2025.
  • Lipocine's Assets Average's 5-year high stood at $50.0 million during Q1 2022, with a 5-year trough of $17.3 million in Q3 2025.
  • For the 5-year period, Lipocine's Assets Average averaged around $32.7 million, with its median value being $32.3 million (2023).
  • Per our database at Business Quant, Lipocine's Assets Average surged by 11978.85% in 2021 and then plummeted by 3795.61% in 2023.
  • Over the past 5 years, Lipocine's Assets Average (Quarter) stood at $46.4 million in 2021, then dropped by 17.13% to $38.5 million in 2022, then tumbled by 37.96% to $23.9 million in 2023, then decreased by 9.52% to $21.6 million in 2024, then decreased by 19.81% to $17.3 million in 2025.
  • Its last three reported values are $17.3 million in Q3 2025, $19.5 million for Q2 2025, and $21.5 million during Q1 2025.